Lewington Sarah, Whitlock Gary, Clarke Robert, Sherliker Paul, Emberson Jonathan, Halsey Jim, Qizilbash Nawab, Peto Richard, Collins Rory
CTSU, University of Oxford, Oxford OX3 7LF, UK.
Lancet. 2007 Dec 1;370(9602):1829-39. doi: 10.1016/S0140-6736(07)61778-4.
Age, sex, and blood pressure could modify the associations of total cholesterol (and its main two fractions, HDL and LDL cholesterol) with vascular mortality. This meta-analysis combined prospective studies of vascular mortality that recorded both blood pressure and total cholesterol at baseline, to determine the joint relevance of these two risk factors.
Information was obtained from 61 prospective observational studies, mostly in western Europe or North America, consisting of almost 900,000 adults without previous disease and with baseline measurements of total cholesterol and blood pressure. During nearly 12 million person years at risk between the ages of 40 and 89 years, there were more than 55,000 vascular deaths (34,000 ischaemic heart disease [IHD], 12,000 stroke, 10,000 other). Information about HDL cholesterol was available for 150,000 participants, among whom there were 5000 vascular deaths (3000 IHD, 1000 stroke, 1000 other). Reported associations are with usual cholesterol levels (ie, corrected for the regression dilution bias).
1 mmol/L lower total cholesterol was associated with about a half (hazard ratio 0.44 [95% CI 0.42-0.48]), a third (0.66 [0.65-0.68]), and a sixth (0.83 [0.81-0.85]) lower IHD mortality in both sexes at ages 40-49, 50-69, and 70-89 years, respectively, throughout the main range of cholesterol in most developed countries, with no apparent threshold. The proportional risk reduction decreased with increasing blood pressure, since the absolute effects of cholesterol and blood pressure were approximately additive. Of various simple indices involving HDL cholesterol, the ratio total/HDL cholesterol was the strongest predictor of IHD mortality (40% more informative than non-HDL cholesterol and more than twice as informative as total cholesterol). Total cholesterol was weakly positively related to ischaemic and total stroke mortality in early middle age (40-59 years), but this finding could be largely or wholly accounted for by the association of cholesterol with blood pressure. Moreover, a positive relation was seen only in middle age and only in those with below-average blood pressure; at older ages (70-89 years) and, particularly, for those with systolic blood pressure over about 145 mm Hg, total cholesterol was negatively related to haemorrhagic and total stroke mortality. The results for other vascular mortality were intermediate between those for IHD and stroke.
Total cholesterol was positively associated with IHD mortality in both middle and old age and at all blood pressure levels. The absence of an independent positive association of cholesterol with stroke mortality, especially at older ages or higher blood pressures, is unexplained, and invites further research. Nevertheless, there is conclusive evidence from randomised trials that statins substantially reduce not only coronary event rates but also total stroke rates in patients with a wide range of ages and blood pressures.
年龄、性别和血压可能会改变总胆固醇(及其主要的两个组分,高密度脂蛋白和低密度脂蛋白胆固醇)与血管性死亡率之间的关联。这项荟萃分析综合了对血管性死亡率的前瞻性研究,这些研究在基线时记录了血压和总胆固醇,以确定这两个危险因素的联合相关性。
从61项前瞻性观察性研究中获取信息,这些研究大多来自西欧或北美,涉及近90万名无既往疾病且有总胆固醇和血压基线测量值的成年人。在40至89岁的近1200万人年的风险期内,有超过55000例血管性死亡(34000例缺血性心脏病[IHD]、12000例中风、10000例其他)。150000名参与者有高密度脂蛋白胆固醇信息,其中有5000例血管性死亡(3000例IHD、1000例中风、1000例其他)。报告的关联是与通常的胆固醇水平(即校正了回归稀释偏倚)相关。
在大多数发达国家胆固醇的主要范围内,总胆固醇每降低1 mmol/L,40至49岁、50至69岁和70至89岁的两性IHD死亡率分别降低约一半(风险比0.44[95%CI 0.42 - 0.48])、三分之一(0.66[0.65 - 0.68])和六分之一(0.83[0.81 - 0.85]),且无明显阈值。随着血压升高,比例风险降低幅度减小,因为胆固醇和血压的绝对效应大致呈相加关系。在涉及高密度脂蛋白胆固醇的各种简单指标中,总胆固醇/高密度脂蛋白胆固醇比值是IHD死亡率最强的预测指标(比非高密度脂蛋白胆固醇信息量多40%,比总胆固醇信息量多一倍以上)。总胆固醇与中年早期(40至59岁)的缺血性和总中风死亡率呈弱正相关,但这一发现很大程度上或完全可由胆固醇与血压的关联来解释。此外,仅在中年且血压低于平均水平的人群中观察到正相关;在老年(70至89岁),特别是收缩压超过约145 mmHg的人群中,总胆固醇与出血性和总中风死亡率呈负相关。其他血管性死亡率的结果介于IHD和中风之间。
总胆固醇在中年和老年以及所有血压水平下均与IHD死亡率呈正相关。胆固醇与中风死亡率缺乏独立的正相关,尤其是在老年或高血压水平时,其原因尚不清楚,有待进一步研究。然而,随机试验中有确凿证据表明他汀类药物不仅能大幅降低广泛年龄和血压患者的冠心病事件发生率,还能降低总中风发生率。